Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies

ISSN： 1460-2156

Source： Brain, Vol.131, Iss.4, 2008-04, pp. : 902-917

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The role of opioids in restless legs syndrome: an [ 11 C]diprenorphine PET study

By von Spiczak Sarah

Brain, Vol. 128, Iss. 4, 2005-04 ,pp. : 906-917

Oxford University Press

Access to resources Recommend Favorite

Rotigotine transdermal system for the treatment of restless legs syndrome

By Wu Anny Wagner Mary L

Future Neurology, Vol. 4, Iss. 3, 2009-05 ,pp. : 267-277

Future Medicine

Access to resources Recommend Favorite

Factor analysis of the International Restless Legs Syndrome Study Group's scale for restless legs severity

By Allen R.P. Kushida C.A. Atkinson M.J. RLS QoL Consortium

Sleep Medicine, Vol. 4, Iss. 2, 2003-03 ,pp. : 133-135

Elsevier

Access to resources Recommend Favorite

Treatment of idiopathic restless legs syndrome (RLS) with slow-release valproic acid compared with slow-release levodopa/benserazid: A randomized, placebo-controlled, double-blind, cross-over study

By Eisensehr Ilonka Ehrenberg Bruce Rogge Solti Silvia Noachtar Soheyl

Journal of Neurology, Vol. 251, Iss. 5, 2004-05 ,pp. : 579-583

Springer Publishing Company

Access to resources Recommend Favorite

Migraine and restless legs syndrome: is there an association?

By Cannon Paul

The Journal of Headache and Pain, Vol. 12, Iss. 4, 2011-08 ,pp. : 405-409

Springer Publishing Company

Access to resources Recommend Favorite